Press Releases

09 Mar

Uncategorized

Morphs into Global Licensing Play with $36 Million in Milestone Payments

• March 9, 2022
• By admin
• 0 comments

EastGate is more than just a drug development company with an oral insulin formulation and an Aging Clinic Surgery Center in Canada. It...

Continue reading

09 Mar

Uncategorized

EastGate Biotech Strikes Investment and Licensing Collaboration with Nico Innovapharma for Liquid Insulin Mouth Rinse Solution for the European Market

• March 9, 2022
• By admin
• 0 comments

FOR IMMEDIATE RELEASE Investment and Product License includes licensing fee and development costs WEST CALDWELL, N.J. and TOR...

Continue reading

09 Mar

Uncategorized

EastGate Biotech Enters into a Financial Agreement

• March 9, 2022
• By admin
• 0 comments

EastGate Biotech Enters into a Financial Agreement Terms of the Agreement reflects long term vision and supports company’s busin...

Continue reading

09 Mar

Uncategorized

EastGate Biotech Announces Joint Venture with Netris/Origin Biopharmaceuticals for Pakistani Market

• March 9, 2022
• By admin
• 0 comments

Drug Development and Nutraceuticals Covered in JV.   WEST CALDWELL, NJ and TORONTO, April 17, 2018 (AccessNewswire-) Eas...

Continue reading

09 Mar

Uncategorized

EastGate Biotech Announces Definitive Agreement with Genluiching Mining Corporation.

• March 9, 2022
• By admin
• 0 comments

EastGate to receive funding in tranches up to $5 million USD.   WEST CALDWELL, NJ and TORONTO, April 10, 2018 (AccessNewswire-) ...

Continue reading

09 Mar

Uncategorized

EastGate Biotech Corp., CEO Anna Gluskin and President, Rose Perri Visit Uptick Newswire’s “Stock Day” with Everett Jolly

• March 9, 2022
• By admin
• 0 comments

https://finance.yahoo.com/news/eastgate-biotech-corp-ceo-anna-120000005.html

Continue reading

09 Mar

Uncategorized

EastGate Biotech Announces that it has reached a Definitive Settlement Agreement with Northbridge Financial Inc..

• March 9, 2022
• By admin
• 0 comments

The Share Reserve with Transfer Agent has been cancelled and all remaining shares have been returned to EastGate Biotech. WEST C...

Continue reading

09 Mar

Uncategorized

EASTGATE BIOTECH ENTERS INTO A MOU WITH GENLUICHING MINING CORP. & AAH & INTERNATIONAL ASSOCIATES INC. OF THE PHILIPPINES

• March 9, 2022
• By admin
• 0 comments

WEST CALDWELL, NJ and TORONTO, March 13, 2018 (AccessNewswire-) EastGate Biotech Corp. (PinkSheets: ETBI), a pharmaceutical company...

Continue reading

09 Mar

Uncategorized

EASTGATE BIOTECH ANNOUNCES LICENSING/DISTRIBUTION MOU WITH BUPHARCO FOR THE INSULIN MOUTH RINSE IN THE PHILIPPINES FOR TYPE 2 DIABETES PATIENTS

• March 9, 2022
• By admin
• 0 comments

WEST CALDWELL, NJ and TORONTO, March 5, 2018 (AccessNewswire-) EastGate Biotech Corp. (PinkSheets: ETBI), a pharmaceutical company that...

Continue reading

09 Mar

Uncategorized

EASTGATE BIOTECH ANNOUNCES LICENSING/DISTRIBUTION MOU WITH BUPHARCO FOR THE INSULIN MOUTH RINSE IN THE PHILIPPINES FOR TYPE 2 DIABETES PATIENTS

• March 9, 2022
• By admin
• 0 comments

WEST CALDWELL, NJ and TORONTO, March 5, 2018 (AccessNewswire-) EastGate Biotech Corp. (PinkSheets: ETBI), a pharmaceutical company ...

Continue reading